Page last updated: 2024-10-22

amobarbital and Diabetes Mellitus

amobarbital has been researched along with Diabetes Mellitus in 2 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BONOMI, U1
GINOULHIAC, E1
TENCONI, LT1
Terplan, M1
Unger, AM1

Other Studies

2 other studies available for amobarbital and Diabetes Mellitus

ArticleYear
["IN VITRO" METABOLISM OF 3-OH-ANTHRANILIC ACID OF THE LIVER OF THE DIABETIC RAT DUE TO PANCREATECTOMY].
    Acta vitaminologica, 1964, Volume: 18

    Topics: Amobarbital; Diabetes Mellitus; In Vitro Techniques; Liver; Metabolism; ortho-Aminobenzoates; Pancre

1964
Survival following massive barbiturate ingestion.
    JAMA, 1966, Oct-17, Volume: 198, Issue:3

    Topics: Amobarbital; Diabetes Mellitus; Humans; Kidneys, Artificial; Male; Metaraminol; Middle Aged; Penicil

1966